Tag: large volume parenteral (lvp) market growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Anticipated CAGR of the Large Volume Parenteral (LVP) Market, and What Factors Will Drive It?#_x000D_

The market size of large volume parenteral (lvp) has seen considerable expansion in the past years. The predicted growth is from $12.52 billion in 2024 to $13.53 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The upsurge during the historic period is due to several factors, such as the rise in chronic diseases, an increase in the elderly population, growing demand for sterile pharmaceuticals, the expansion of healthcare infrastructure, and development in regulatory frameworks for pharmaceutical products._x000D_

_x000D_

Strong growth is anticipated in the large volume parenteral (lvp) market in the coming years, with it estimated to reach$19.38 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The surge in the forthcoming timeframe is spurred by increasing demand for biologics and biosimilars, higher healthcare spending, the growth of the pharmaceutical outsourcing sector, attention towards personalized medicine, and the globalization of pharmaceutical supply chains. Key trends within this forecast period include advancements in manufacturing technology, incorporation of cutting-edge technology in pharmaceutical production, the use of single-use technologies, the creation of high-strength formulas, and the increased application of 3D printing in pharmaceuticals._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Large Volume Parenteral (LVP) Market?#_x000D_

The large-volume parenteral market is predicted to expand due to the increasing instances of chronic illnesses. Chronic diseases are typically long-term health conditions, typically lasting three months or more, and have the potential to deteriorate over time. The surge in chronic illnesses is predominantly due to tobacco consumption, exposure to smoke, and inadequate nutrition. For these patients, maintaining a balanced intake of crucial nutrients is necessary to maintain strength, and the parenteral method of administration ensures the proper medicinal dosage, as the majority of the drug is directly absorbed into circulation, bypassing the digestive system. In September 2023, the World Health Organization, a United Nations specialized agency based in Switzerland, reported 41 million deaths, equating to 74% of all deaths globally due to non-communicable diseases (NCDs) or chronic diseases. As such, the increasing prevalence of chronic diseases is fueling the expansion of the large-volume parenteral market._x000D_

_x000D_

#How Is the Large Volume Parenteral (LVP) Market Segmented?#_x000D_

The large volume parenteral (lvp)market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Soft Bag LVP; Plastic Bag LVP; Glass Bottle LVP_x000D_

2) By Volume: 100 ML – 250 ML; 250 ML – 500 ML; 500 ML – 1000 ML; 1000 ML -2000 ML; 2000 And More_x000D_

3) By Application: Basic Infusion; Therapeutics Infusion; Nutritious Infusion_x000D_

4) By End-User: Hospital; Medical Centers; Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Soft Bag LVP: PVC Soft Bags; Non-PVC Soft Bags _x000D_

2) By Plastic Bag LVP: Polypropylene Bags; Polyethylene Bags _x000D_

3) By Glass Bottle LVP: Single-Use Glass Bottles; Multi-Dose Glass Bottles _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Large Volume Parenteral (LVP) Market Growth?#_x000D_

North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Large Volume Parenteral (LVP) Market?#_x000D_

The emergence of product innovation as a significant trend in the large-volume parenteral market has been noted. Main players in the market are focusing their attention on developing novel products to consolidate their market position. As an example, SGD Pharma SA, a firm based in France that produces molded and tubular glass for primary pharmaceutical packaging, introduced 100-ml type I molded glass vials in March 2022. These vials are sterile and prepared for aseptic filling and finalizing of parenteral medicinal substances. They contribute to the reduction of vial scratches, aid in visual inspection of the filled vial, and lessen the chances of rejection during quality assurance checks._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report_x000D_

_x000D_

#How Is the Large Volume Parenteral (LVP) Market Defined and What Are Its Core Parameters?#_x000D_

Large volume parenteral (LVP) refers to sterile intravenous solutions of a volume of 100 ml or more that are terminally sterilized by heat. They are used for intravenous infusions to administer hydration, nourishment, and medicine._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Large Volume Parenteral (LVP) Market?

The market size of large volume parenteral (LVP) has witnessed considerable expansion in the recent past. The market, which is currently valued at $12.52 billion as of 2024, is projected to increase to $13.57 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The considerable growth during the historic period can largely be credited to the rising instances of chronic illnesses, an escalation in the elderly population, growing demand for germ-free pharmaceuticals, enhancement of healthcare provisions, and the establishment of regulatory directives in relation to pharmaceuticals.

What Growth Rate Is Forecasted for the Large Volume Parenteral (LVP) Market by 2029?

In the forthcoming years, robust growth is anticipated in the large volume parenteral (LVP) market. The market is projected to expand to $19.46 billion in 2029 with a 9.4% compound annual growth rate (CAGR). The forecasted growth can be linked to the escalating demand for biologics and biosimilars, augmented healthcare spending, broadening of pharmaceutical outsourcing, an amplified focus on personalized medicine, and internationalization of pharmaceutical supply chains. Key trends during the forecast period include advancements in manufacturing procedures, incorporation of cutting-edge technologies in drug production, application of single-use technologies, development of highly concentrated formulations, and an uptick in the use of 3D printing for pharmaceutical applications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Which Key Companies Are Shaping the Future of the Large Volume Parenteral (LVP) Market?

Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

Which Factors Are Driving Demand in the Large Volume Parenteral (LVP) Industry?

The surge in chronic ailments is anticipated to accelerate the expansion of the large-volume parenteral market. Chronic ailments are diseases or conditions that usually endure for three months or more and may intensify over time. The escalation in such diseases is primarily fueled by the usage of tobacco, exposure to smoke, and inadequate nutrition. These patients necessitate an optimal balance of vital nutrients that bolster the retention of strength. The parenteral method of administration ensures the correct pharmaceutical dosage as it lets most of the medication be directly absorbed into the bloodstream, bypassing the digestive system. To exemplify, as per the World Health Organization, a Switzerland-based specialized agency of the United Nations, in September 2023, there were 41 million deaths or 74% of the total deaths resulting from non-communicable diseases (NCDs) or chronic diseases globally each year. Hence, the escalating prevalence of chronic diseases boosts the expansion of the large-volume parenteral market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

How Is the Large Volume Parenteral (LVP) Market Segmented by Several Divisions?

The large volume parenteral (LVP) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

What are the Emerging Market Trends Driving the Growth of the Large Volume Parenteral (LVP) Industry?

Product innovation has catapulted to prominence as a primary trend in the large-volume parenteral market. Major participants in the market are channeling their energies towards the development of creative items to cement their market standing. For instance, SGD Pharma SA, a company based in France that specializes in the production of molded and tubular glass for primary pharmaceutical packaging, introduced 100-ml type I molded glass vials in March 2022. These vials are sterile and ready for the aseptic filling and finishing of parenteral medicinal solutions. This innovation not only prevents vial scratches but also aids in the visual inspection of the filled vial and reduces the chance of rejection in quality control.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Which Regions Are Driving Growth in the Large Volume Parenteral (LVP) Market?

North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195

This Report Delivers Insight On:

1. How big is the large volume parenteral (lvp) market, and how is it changing globally?

2. Who are the major companies in the large volume parenteral (lvp) market, and how are they performing?

3. What are the key opportunities and risks in the large volume parenteral (lvp) market right now?

4. Which products or customer segments are growing the most in the large volume parenteral (lvp) market?

5. What factors are helping or slowing down the growth of the large volume parenteral (lvp) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theLarge Volume Parenteral (LVP) Market?

The increasing incidence of chronic diseases is anticipated to stimulate the expansion of the large-volume parenteral market. Chronic diseases are typically long-term illnesses or conditions that can progressively deteriorate over time. The escalation of chronic diseases is primarily influenced by tobacco usage, exposure to smoke, and inadequate nutrition. Adequate proportions of vital nutrients necessary for maintaining strength are crucial for these patients, and the parenteral administration method allows the ensurement of the right pharmaceutical dose as most medication is directly absorbed into the bloodstream, bypassing the gastrointestinal system. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2023 that there were 41 million deaths worldwide, accounting for 74% of those caused by non-communicable diseases (NCDs) or chronic diseases annually. Hence, the escalating incidence of chronic diseases is propelling the growth of the large-volume parenteral market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

#What Growth Opportunities Will Drive the Large Volume Parenteral (LVP) Market’s CAGR Through 2034?

The substantial size of the large volume parenteral (LVP) market has been on a constant upswing in the previous years. It’s predicted to escalate from $12.52 billion in 2024 to $13.57 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to the growth during the historical period include increasing incidence of chronic illnesses, enlargement of the elderly population, higher requirement for sterile pharmaceuticals, growth in the healthcare infrastructure, and the evolution of regulatory guidelines for pharmaceuticals.

The size of the large volume parenteral (LVP) market is anticipated to experience significant expansion in the coming years and is predicted to reach a valuation of $19.46 billion by 2029, progressing at a compound annual growth rate (CAGR) of 9.4%. This surge during the forecast period can be credited to a rising demand for biologics and biosimilars, escalated healthcare spending, the broadening scope of pharmaceutical outsourcing, an increased emphasis on personalized medication, and the international expansion of pharmaceutical supply networks. Foreseen trends for the forecast period consist of advancements in manufacturing procedures, the incorporation of high-tech procedures in pharmaceutical manufacturing, the employment of single-use technologies, the creation of high-concentration mixtures, and the growing use of 3d printing in pharmaceutical applications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195

Which Upcoming Market Trends and Innovations Are Set to Influence theLarge Volume Parenteral (LVP) Market’s Path Forward?

The rise of product innovation has been identified as a crucial trend gaining traction in the large-volume parenteral market. Key market participants are focusing their resources on the development of innovative products to consolidate their standing in the market. For example, SGD Pharma SA, a France-originated manufacturer of molded and tubular glass for pharmaceutical primary packaging, introduced 100-ml type I molded glass vials in March 2022. These vials, which are sterile and prepped for aseptic filling and finishing of parenteral medicinal formulations, aid in the prevention of vial scratches, facilitate visual inspection of the filled vial, and minimize the risk of rejection during quality control checks.

Who Are the Dominant Market Players Pushing the Boundaries of theLarge Volume Parenteral (LVP) Market?

Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The large volume parenteral (LVP) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

What Regions Are Dominating the Large Volume Parenteral (LVP) Market Growth?

North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Large Volume Parenteral (LVP) Maret 2025, By The Business Research Company:

Wastewater Treatment Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wastewater-treatment-equipment-global-market-report

Waste Disposable Units Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/waste-disposable-units-global-market-report

Mining Support Activities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mining-support-activities-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: